Psoriasis induced by topically applied indomethacin.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to N B Zlatkov.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The anti-DNA antibody titer (heat denatured, native and monostranded) was studied in 61 patients with psoriasis and 41 healthy controls. Positive titers of anti-DNA antibodies were established in 19.3% of the psoriatics and in 4.9% of the controls. Antibodies against heat-denatured DNA were discovered in 8.2% of the patients and in 0% of the healthy persons; against native DNA in 18% of the psoriatics and 4.9% of the controls and against monostranded DNA in 31.7% of the psoriasis patients and 9.8% of the control group. In general, the percentage of the positive titers of anti-DNA antibodies in psoriatics was about 4 times higher than that of the healthy controls.
Free fatty acids in the serum of 60 patients with generalized psoriasis were studied by a gas-chromatographic method. The same investigations in 40 healthy persons served for control purposes. It was established with statistical probability (p less than 0.001) that in the serum of psoriatics the levels of palmitic (C 16: 0), stearic (C 18: 0), arachidic (C 20: 0), and docosadienic (C 20: 2) acids were increased, while the levels of the linoleic (C 18: 2) and arachidonic (C 20: 4) acids were depressed. There is no behenic acid (C 22: 0) in the blood serum of psoriatics. Thalassotherapy caused no significant changes in the levels of these free fatty acids in psoriatics.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.